The development and validation of prognostic and predictive biomarkers in breast cancer is limited by the availability of …
Matthew D. Sutcliffe,
Kevin R. Mott,
Tulay Yilmaz-Swenson,
Brooke M. Felsheim,
Alexander V. Lobanov,
Anna R. Michmerhuizen,
Patrick D. Rädler,
Denis O. Okumu,
Xiaping He,
Adam D. Pfefferle,
Stephanie Dance-Barnes,
Christian Brueffer,
Lao H. Saal,
Michael P. East,
Daniel P. Hollern,
Timothy C. Elston,
Gary L. Johnson,
Charles M. Perou